Patient and Device Selection in Pediatric MCS: A Review of Current Consensus and Unsettled Questions

Joshua M Friedland-Little1, Anna Joong2, Svetlana B Shugh3

  • 1Division of Cardiology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA. Joshua.friedland-little@seattlechildrens.org.

Pediatric Cardiology
|March 24, 2022
PubMed

Insights

Pediatric ventricular assist device (VAD) use is increasing, but selection guidance is lacking. This review highlights areas needing more research for optimal outcomes in children with advanced heart failure.

Area of Science:

  • Pediatric Cardiology
  • Mechanical Circulatory Support
  • Heart Failure Management

Background:

  • Pediatric ventricular assist device (VAD) use has grown substantially, with one-third of pediatric heart transplant recipients now bridged with a VAD.
  • Despite increased utilization, formal guidelines for patient or device selection in pediatric VAD therapy are limited.
  • Outcomes in pediatric VAD support are known to vary based on patient size, anatomy, illness severity, and device type.

Purpose of the Study:

  • To survey current practice patterns in pediatric VAD patient and device selection.
  • To review existing literature on VAD outcomes specific to pediatric patient populations.
  • To identify patient groups lacking a consensus approach for optimal VAD outcomes, guiding future research.

Main Methods:

  • Survey of clinical decision-making among member sites of the Advanced Cardiac Therapies Improving Outcomes Network (ACTION).
  • Comprehensive literature review focusing on patient population-specific VAD outcomes.
  • Analysis of center-specific practices related to patient and device selection in pediatric VADs.

Main Results:

  • Current pediatric VAD practice patterns reveal heterogeneity in patient and device selection.
  • Significant variation in VAD outcomes exists across different pediatric patient subgroups.
  • Specific pediatric populations lack a clear consensus for achieving optimal VAD outcomes.

Conclusions:

  • Contemporary approaches to pediatric VAD patient and device selection are presented.
  • Key populations requiring further research and quality improvement efforts for VAD therapy are highlighted.
  • Addressing knowledge gaps in VAD selection for specific pediatric groups is crucial for improving outcomes.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
1.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
47